Market Performance - The Sci-Tech Innovation Board (STAR Market) index fell by 0.01%, closing at 984.80 points, with a total trading volume of 2.973 billion shares and a turnover of 102.415 billion yuan, resulting in an average turnover rate of 1.67% [1] - Among the tradable stocks on the STAR Market, 126 stocks closed higher, with 5 stocks rising over 10% and 9 stocks rising between 5% and 10%. Conversely, 456 stocks closed lower, with 2 stocks declining over 10% [1] Stock Turnover Rates - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 6 stocks had rates between 10% and 20%, 63 stocks had rates between 5% and 10%, 89 stocks had rates between 3% and 5%, 284 stocks had rates between 1% and 3%, and 144 stocks had rates below 1% [1] - The stock with the highest turnover rate was Xinyuren, which closed down by 12.03% with a turnover rate of 27.05% and a trading volume of 457 million yuan. Jin Chengzi followed with a 5.51% increase and a turnover rate of 26.74% [1] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 21 stocks. The electronics and machinery equipment sectors followed with 15 and 9 stocks, respectively [2] Fund Flow - Among the high turnover stocks, 32 stocks experienced net inflows of main funds, with the highest net inflows seen in Huanyu Pharmaceutical (119 million yuan), Rejing Biological (79.625 million yuan), and Daqian Energy (55.749 million yuan). Conversely, the stocks with the highest net outflows included Yuanjie Technology (82.4535 million yuan), Juxin Technology (82.4145 million yuan), and Rongbai Technology (70.9039 million yuan) [2] Leverage Fund Movements - A total of 50 stocks with high turnover recently received net purchases from leveraged funds. Notably, stocks with significant increases in financing balances included Kexing Pharmaceutical (97.5237 million yuan), Weichip Bio (92.6148 million yuan), and Ruikeda (76.3542 million yuan). In contrast, stocks with notable decreases in financing balances included Rongchang Biological (60.2381 million yuan), Haibo Sichuang (56.7112 million yuan), and Guangda Special Materials (37.4973 million yuan) [3]